Purchase Order 75N91021P00959
Award Date 9/24/21
Potential Completion Date 9/23/24
Potential Value $3.1M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $3,182.40 firm fixed price delivery order is for gene synthesis services. Genscript specializes in providing customized DNA, antibodies, proteins, peptides, and other molecular biology products and services to support biomedical research and public health initiatives...
- This firm fixed price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $15,289.00 contract will run through September 30, 2024 and does not have a set-aside designation. Genscript specializes in gene synthesis, gene editing, custom protein and antibody production, and other molecular biology services that support...
- This firm fixed price delivery order awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Genscript USA Inc., a for-profit biotechnology company, has a potential value of $8,163.25. The award is for peptide services and does not have a set-aside designation. Genscript is a provider of gene synthesis, gene editing, protein production, and other molecular biology services to various federal agencies, including the NIH, CDC, FDA, and...
- This firm fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $3,943.72 contract is for custom gene synthesis services to support NIAID's biomedical research programs. Genscript, a for-profit organization, has a strong track record of providing specialized molecular biology products and services to...
- This contract was awarded by the National Institutes of Health (NIH) National Cancer Institute to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $5,353.40 firm fixed price delivery order is for peptide services and was completed on September 9, 2015. The contract has no set-aside designation. Genscript is a supplier of various products and services to federal agencies, including gene synthesis, gene editing, custom protein and antibody production, and...
- This firm fixed-price federal contract award to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey, is for $3,078,000.00 to provide synthesis services for custom biomolecules (gene constructs and peptides) in support of the National Cancer Institute's (NCI) Center for Cancer Research (CCR) Surgery Branch. The contract, which does not have a set-aside designation, will run through September 23, 2027. This award was made in response to a solicitation issued by the Department...
- This federal contract award was made by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $7,465.65 firm fixed-price delivery order supports Genscript's provision of peptide and gene synthesis services to the agency. While the contract does not have a set-aside designation, Genscript has received previous small business awards from the National Institutes of...
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company, for custom gene synthesis services. The contract has a potential value of $21,275.80 and a completion date of August 19, 2020. Genscript, based in Piscataway, New Jersey, specializes in gene synthesis, gene editing, custom protein and...
- This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS), to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $3,464.90 contract is for peptide services and was awarded on September 8, 2015 with a completion date of September 9, 2015. The award does not have a set-aside designation. Genscript has received numerous prime and subcontracts from...
- <p>The National Cancer Institute awarded a purchase order to Genscript USA Inc. for $12,098.14 on May 5, 2021, for custom gene synthesis, custom peptide synthesis, direct cloning, plasmid preparation, and crude peptide library services. The order carries no small business set-aside. Work is performed in Piscataway, New Jersey, with an ultimate completion date of June 15, 2021.</p>